Gene Therapy-based Drug Market - Global Outlook and Forecast 2021-2027

Name: Gene Therapy-based Drug Market - Global Outlook and Forecast 2021-2027
Brand: KnowledgeNJournals Research
SKU: Pharmaceuticals and Healthcare
Price: 3250 USD
Availability: InStock
Rating: 4.5 (37 reviews)

Report Code: KNJ759045 | No. of Pages: 93 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Jun-2021

The Gene Therapy-based Drug market report provides the overall market analysis of the industry. This market report presents the current snapshot of the Gene Therapy-based Drug market to understand the market's key features. The content of the report highlights the important market criteria that help to develop the market further. The report provides the value and the volume of the Gene Therapy-based Drug at global, regional, and company levels. The historical market value for the year 2021 along with the market value for the upcoming year 2027 has been presented in the market report. Along with that, the report also provides information on subjects such as Export, import, production, and production capacity of the Gene Therapy-based Drug market.This report contains market size and forecasts of Gene Therapy-based Drug in Global, including the following market information:
Global Gene Therapy-based Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Gene Therapy-based Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Therapy-based Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy-based Drug Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Gene Therapy-based Drug Market Segment Percentages, By Type, 2020 (%)
Viral Gene Delivery System
Non-viral Gene Delivery System

China Gene Therapy-based Drug Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Gene Therapy-based Drug Market Segment Percentages, By Application, 2020 (%)
Neurological Diseases
Cancer
Other

Global Gene Therapy-based Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Gene Therapy-based Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Gene Therapy-based Drug Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Gene Therapy-based Drug Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

1 Introduction to Research & Analysis Reports
    1.1 Gene Therapy-based Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Gene Therapy-based Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy-based Drug Overall Market Size
    2.1 Global Gene Therapy-based Drug Market Size: 2021 VS 2027
    2.2 Global Gene Therapy-based Drug Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Gene Therapy-based Drug Players in Global Market
    3.2 Top Global Gene Therapy-based Drug Companies Ranked by Revenue
    3.3 Global Gene Therapy-based Drug Revenue by Companies
    3.4 Top 3 and Top 5 Gene Therapy-based Drug Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Gene Therapy-based Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy-based Drug Players in Global Market
        3.6.1 List of Global Tier 1 Gene Therapy-based Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy-based Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Gene Therapy-based Drug Market Size Markets, 2021 & 2027
        4.1.2 Viral Gene Delivery System
        4.1.3 Non-viral Gene Delivery System
    4.2 By Type - Global Gene Therapy-based Drug Revenue & Forecasts
        4.2.1 By Type - Global Gene Therapy-based Drug Revenue, 2016-2021
        4.2.2 By Type - Global Gene Therapy-based Drug Revenue, 2022-2027
        4.2.3 By Type - Global Gene Therapy-based Drug Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Gene Therapy-based Drug Market Size, 2021 & 2027
        5.1.2 Neurological Diseases
        5.1.3 Cancer
        5.1.4 Other
    5.2 By Application - Global Gene Therapy-based Drug Revenue & Forecasts
        5.2.1 By Application - Global Gene Therapy-based Drug Revenue, 2016-2021
        5.2.2 By Application - Global Gene Therapy-based Drug Revenue, 2022-2027
        5.2.3 By Application - Global Gene Therapy-based Drug Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Gene Therapy-based Drug Market Size, 2021 & 2027
    6.2 By Region - Global Gene Therapy-based Drug Revenue & Forecasts
        6.2.1 By Region - Global Gene Therapy-based Drug Revenue, 2016-2021
        6.2.2 By Region - Global Gene Therapy-based Drug Revenue, 2022-2027
        6.2.3 By Region - Global Gene Therapy-based Drug Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Gene Therapy-based Drug Revenue, 2016-2027
        6.3.2 US Gene Therapy-based Drug Market Size, 2016-2027
        6.3.3 Canada Gene Therapy-based Drug Market Size, 2016-2027
        6.3.4 Mexico Gene Therapy-based Drug Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Gene Therapy-based Drug Revenue, 2016-2027
        6.4.2 Germany Gene Therapy-based Drug Market Size, 2016-2027
        6.4.3 France Gene Therapy-based Drug Market Size, 2016-2027
        6.4.4 U.K. Gene Therapy-based Drug Market Size, 2016-2027
        6.4.5 Italy Gene Therapy-based Drug Market Size, 2016-2027
        6.4.6 Russia Gene Therapy-based Drug Market Size, 2016-2027
        6.4.7 Nordic Countries Gene Therapy-based Drug Market Size, 2016-2027
        6.4.8 Benelux Gene Therapy-based Drug Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Gene Therapy-based Drug Revenue, 2016-2027
        6.5.2 China Gene Therapy-based Drug Market Size, 2016-2027
        6.5.3 Japan Gene Therapy-based Drug Market Size, 2016-2027
        6.5.4 South Korea Gene Therapy-based Drug Market Size, 2016-2027
        6.5.5 Southeast Asia Gene Therapy-based Drug Market Size, 2016-2027
        6.5.6 India Gene Therapy-based Drug Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Gene Therapy-based Drug Revenue, 2016-2027
        6.6.2 Brazil Gene Therapy-based Drug Market Size, 2016-2027
        6.6.3 Argentina Gene Therapy-based Drug Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Gene Therapy-based Drug Revenue, 2016-2027
        6.7.2 Turkey Gene Therapy-based Drug Market Size, 2016-2027
        6.7.3 Israel Gene Therapy-based Drug Market Size, 2016-2027
        6.7.4 Saudi Arabia Gene Therapy-based Drug Market Size, 2016-2027
        6.7.5 UAE Gene Therapy-based Drug Market Size, 2016-2027
7 Players Profiles
    7.1 Biogen
        7.1.1 Biogen Corporate Summary
        7.1.2 Biogen Business Overview
        7.1.3 Biogen Gene Therapy-based Drug Major Product Offerings
        7.1.4 Biogen Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.1.5 Biogen Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Gene Therapy-based Drug Major Product Offerings
        7.2.4 Novartis Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.2.5 Novartis Key News
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Corporate Summary
        7.3.2 Gilead Sciences Business Overview
        7.3.3 Gilead Sciences Gene Therapy-based Drug Major Product Offerings
        7.3.4 Gilead Sciences Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.3.5 Gilead Sciences Key News
    7.4 Sarepta Therapeutics
        7.4.1 Sarepta Therapeutics Corporate Summary
        7.4.2 Sarepta Therapeutics Business Overview
        7.4.3 Sarepta Therapeutics Gene Therapy-based Drug Major Product Offerings
        7.4.4 Sarepta Therapeutics Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.4.5 Sarepta Therapeutics Key News
    7.5 Alnylam Pharmaceuticals
        7.5.1 Alnylam Pharmaceuticals Corporate Summary
        7.5.2 Alnylam Pharmaceuticals Business Overview
        7.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Major Product Offerings
        7.5.4 Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.5.5 Alnylam Pharmaceuticals Key News
    7.6 Amgen
        7.6.1 Amgen Corporate Summary
        7.6.2 Amgen Business Overview
        7.6.3 Amgen Gene Therapy-based Drug Major Product Offerings
        7.6.4 Amgen Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.6.5 Amgen Key News
    7.7 Spark Therapeutics
        7.7.1 Spark Therapeutics Corporate Summary
        7.7.2 Spark Therapeutics Business Overview
        7.7.3 Spark Therapeutics Gene Therapy-based Drug Major Product Offerings
        7.4.4 Spark Therapeutics Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.7.5 Spark Therapeutics Key News
    7.8 Akcea Therapeutics
        7.8.1 Akcea Therapeutics Corporate Summary
        7.8.2 Akcea Therapeutics Business Overview
        7.8.3 Akcea Therapeutics Gene Therapy-based Drug Major Product Offerings
        7.8.4 Akcea Therapeutics Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.8.5 Akcea Therapeutics Key News
    7.9 bluebird bio
        7.9.1 bluebird bio Corporate Summary
        7.9.2 bluebird bio Business Overview
        7.9.3 bluebird bio Gene Therapy-based Drug Major Product Offerings
        7.9.4 bluebird bio Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.9.5 bluebird bio Key News
    7.10 Sunway Biotech
        7.10.1 Sunway Biotech Corporate Summary
        7.10.2 Sunway Biotech Business Overview
        7.10.3 Sunway Biotech Gene Therapy-based Drug Major Product Offerings
        7.10.4 Sunway Biotech Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.10.5 Sunway Biotech Key News
    7.11 SIBIONO
        7.11.1 SIBIONO Corporate Summary
        7.11.2 SIBIONO Business Overview
        7.11.3 SIBIONO Gene Therapy-based Drug Major Product Offerings
        7.11.4 SIBIONO Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.11.5 SIBIONO Key News
    7.12 AnGes
        7.12.1 AnGes Corporate Summary
        7.12.2 AnGes Business Overview
        7.12.3 AnGes Gene Therapy-based Drug Major Product Offerings
        7.12.4 AnGes Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.12.5 AnGes Key News
    7.13 Orchard Therapeutics
        7.13.1 Orchard Therapeutics Corporate Summary
        7.13.2 Orchard Therapeutics Business Overview
        7.13.3 Orchard Therapeutics Gene Therapy-based Drug Major Product Offerings
        7.13.4 Orchard Therapeutics Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.13.5 Orchard Therapeutics Key News
    7.14 Human Stem Cells Institute
        7.14.1 Human Stem Cells Institute Corporate Summary
        7.14.2 Human Stem Cells Institute Business Overview
        7.14.3 Human Stem Cells Institute Gene Therapy-based Drug Major Product Offerings
        7.14.4 Human Stem Cells Institute Gene Therapy-based Drug Revenue in Global (2016-2021)
        7.14.5 Human Stem Cells Institute Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

Gene Therapy-based Drug Market - Global Outlook and Forecast 2021-2027

NEED Help?

USA : +1 (661) 636 6162

INDIA : +91 9325802062